Annual Total Expenses
$31.10 M
-$9.96 M-24.26%
December 31, 2023
Summary
- As of February 25, 2025, VVOS annual total expenses is $31.10 million, with the most recent change of -$9.96 million (-24.26%) on December 31, 2023.
- During the last 3 years, VVOS annual total expenses has risen by +$9.32 million (+42.81%).
- VVOS annual total expenses is now -24.26% below its all-time high of $41.05 million, reached on December 31, 2022.
Performance
VVOS Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$6.50 M
+$515.00 K+8.60%
September 30, 2024
Summary
- As of February 25, 2025, VVOS quarterly total expenses is $6.50 million, with the most recent change of +$515.00 thousand (+8.60%) on September 30, 2024.
- Over the past year, VVOS quarterly total expenses has stayed the same.
- VVOS quarterly total expenses is now -41.65% below its all-time high of $11.15 million, reached on June 30, 2022.
Performance
VVOS Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
VVOS Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.3% | 0.0% |
| 3 y3 years | +42.8% | -35.3% |
| 5 y5 years | +156.4% | -5.1% |
VVOS Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.3% | at low | -41.6% | +8.6% |
| 5 y | 5-year | -24.3% | +42.8% | -41.6% | +38.7% |
| alltime | all time | -24.3% | +156.4% | -41.6% | +38.7% |
Vivos Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.50 M(+8.6%) |
| Jun 2024 | - | $5.99 M(-16.9%) |
| Mar 2024 | - | $7.20 M(-2.4%) |
| Dec 2023 | $31.10 M(-24.3%) | $7.38 M(+6.3%) |
| Sep 2023 | - | $6.94 M(-12.3%) |
| Jun 2023 | - | $7.91 M(-10.7%) |
| Mar 2023 | - | $8.86 M(-11.5%) |
| Dec 2022 | $41.05 M(+12.9%) | $10.01 M(+3.7%) |
| Sep 2022 | - | $9.65 M(-13.4%) |
| Jun 2022 | - | $11.15 M(+8.4%) |
| Mar 2022 | - | $10.28 M(-5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $36.36 M(+67.0%) | $10.89 M(+8.4%) |
| Sep 2021 | - | $10.05 M(+17.4%) |
| Jun 2021 | - | $8.56 M(+24.9%) |
| Mar 2021 | - | $6.85 M(+10.1%) |
| Dec 2020 | $21.77 M(-0.9%) | $6.22 M(+21.8%) |
| Sep 2020 | - | $5.11 M(+9.0%) |
| Jun 2020 | - | $4.69 M(-18.5%) |
| Mar 2020 | - | $5.75 M(+3.0%) |
| Dec 2019 | $21.97 M(+81.1%) | $5.58 M(-12.4%) |
| Sep 2019 | - | $6.37 M |
| Dec 2018 | $12.13 M | - |
FAQ
- What is Vivos Therapeutics annual total expenses?
- What is the all time high annual total expenses for Vivos Therapeutics?
- What is Vivos Therapeutics annual total expenses year-on-year change?
- What is Vivos Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly total expenses year-on-year change?
What is Vivos Therapeutics annual total expenses?
The current annual total expenses of VVOS is $31.10 M
What is the all time high annual total expenses for Vivos Therapeutics?
Vivos Therapeutics all-time high annual total expenses is $41.05 M
What is Vivos Therapeutics annual total expenses year-on-year change?
Over the past year, VVOS annual total expenses has changed by -$9.96 M (-24.26%)
What is Vivos Therapeutics quarterly total expenses?
The current quarterly total expenses of VVOS is $6.50 M
What is the all time high quarterly total expenses for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly total expenses is $11.15 M
What is Vivos Therapeutics quarterly total expenses year-on-year change?
Over the past year, VVOS quarterly total expenses has changed by $0.00 (0.00%)